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Terminal deoxynucleotidyl transferase (TdT) catalyzes the addition
of nucleotides at the junctions of rearranging Ig and T cell receptor
gene segments, thereby generating antigen receptor diversity. Ku
is a heterodimeric protein composed of 70- and 86-kDa subunits
that binds DNA ends and is required for V(D)J recombination and
DNA double-strand break (DSB) repair. We provide evidence for a
direct interaction between TdT and Ku proteins. Studies with a
baculovirus expression system show that TdT can interact specif-
ically with each of the Ku subunits and with the heterodimer. The
interaction between Ku and TdT is also observed in pre-T cells with
endogenously expressed proteins. The protein–protein interaction
is DNA independent and occurs at physiological salt concentra-
tions. Deletion mutagenesis experiments reveal that the N-termi-
nal region of TdT (131 amino acids) is essential for interaction with
the Ku heterodimer. This region, although not important for TdT
polymerization activity, contains a BRCA1 C-terminal domain that
has been shown to mediate interactions of proteins involved in
DNA repair. The induction of DSBs in Cos-7 cells transfected with
a human TdT expression construct resulted in the appearance of
discrete nuclear foci in which TdT and Ku colocalize. The physical
association of TdT with Ku suggests a possible mechanism by
which TdT is recruited to the sites of DSBs such as V(D)J recombi-
nation intermediates.
Double-strand break repair u V(D)J recombination
V(D)J recombination is a site-specific event that generates theimmune repertoire in mammalian lymphocytes (1). This
event depends on the successful execution of a series of steps by
protein factors, some of which function exclusively during V(D)J
recombination, whereas others are also essential for double-
strand break (DSB) repair (2). Rag1, Rag2, and terminal de-
oxynucleotidyl transferase (TdT) are lymphoid specific and
function only during V(D)J recombination, whereas Ku70,
Ku86, DNA-dependent protein kinase catalytic subunit (DNA-
PKcs), XRCC4, and ligase IV are essential for both V(D)J
recombination and DSB repair. Some of these factors interact
with each other, suggesting a mechanism by which proteins are
recruited to sites of recombination (3, 4).
TdT adds nucleotides in a template-independent manner at
coding ends during recombination of Ig and T cell receptor gene
segments, thereby expanding the diversity of antigen receptors.
It exists as a 58-kDa protein, although smaller products of 55, 44,
32, and 12 kDa have been detected in cell extracts (5). The N
terminus of TdT contains a conserved BRCT-like (BRCA1
C-terminal) sequence, a protein–protein interaction domain (6,
7) that was first identified in the breast cancer suppressor gene
BRCA1 and subsequently found in 50 other proteins, some of
which function in DNA repair and recombination (8, 9).
The Ku autoantigen is a heterodimer composed of 70- and
86-kDa subunits that form the DNA binding component of an
associated 460-kDa DNA-PKcs (3). Ku86-deficient mice are able
to initiate V(D)J recombination, but the intermediates of the
cleavage reaction are not processed, resulting in accumulation of
hairpin coding ends and blunt signal ends (10). The essential role
of Ku in this process led us to ask whether it interacts directly
with TdT, which modifies these intermediates by the insertion of
nucleotides. Notably, the residual coding joints present in
Ku862y2 mice were found to be devoid of N regions, suggesting
that the Ku86 protein might regulate TdT activity in vivo (11).
We have tested whether Ku and TdT interact directly in vitro and
whether such interactions also occur in intact cells treated with
a DNA-damaging agent.
Materials and Methods
Cell Culture. The human Molt-4 (pre-T cell) lymphoblast cell line
was maintained at 37°C in RPMI medium 1640 supplemented
with 10% (volyvol) FBS) and penicillinystreptomycin. Cos-7
cells were maintained at 37°C in DMEM supplemented with
10% (volyvol) FBS. The Sf9 insect cell line was maintained at
27°C in Grace’s insect medium supplemented with 10%
(volyvol) FBS and penicillinystreptomycin.
Construction of Recombinant Baculovirus Constructs. Full-length
human TdT cDNA encoding the 58-kDa protein was cloned into
the baculovirus transfer vector as described (12). The 44-kDa




ruses expressing His-Ku70 and His-Ku86 have been de-
scribed (13).
Antibodies. For Western analysis, rabbit anti-human TdT poly-
clonal (5), mouse anti-polyhistidine (polyHis; Sigma), mouse
anti-human Ku70, N3H10, and Ku86 (Sigma) mAbs were used.
For coimmunoprecipitation, 5100y133D2 (anti-human TdT; ref.
12), N3H10 (anti-human Ku70; ref. 14), 111 (anti-human Ku86;
ref. 15), 162 (anti-human Ku70y86; ref. 14), anti-polyHis, and
polyclonal anti-human DNA-PKcs (PharMingen) antibodies
were used. For immunofluorescence, rabbit anti-human TdT
polyclonal and mouse anti-human Ku86 mAbs were used.
Western Blot Analyses. Cell extracts were prepared in immuno-
precipitationylysis buffer (0.15 M NaCly50 mM Tris, pH
7.5y0.3% NP-40y2 mM EDTA) with protease inhibitor mixture
(Roche Molecular Biochemicals). Equal amounts were electro-
phoresed on SDSyPAGE gels, transferred to a poly(vinylidene
difluoride) (PVDF) membrane, and probed with primary anti-
body followed by incubation in horseradish peroxidase-
conjugated anti-rabbit or anti-mouse IgG secondary (1:4,000
dilution) antibodies. The blots were developed by using the
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enhanced chemiluminescence method (ECL kit, Amersham
Pharmacia).
Immunoprecipitation of Lysates. Lysates were prepared as de-
scribed above. Equal amounts of the lysates were incubated
overnight with antibody at 4°C. Protein A Sepharose beads were
added, and the incubation was continued for 3 h. Bound proteins
were released by boiling in 25 ml of 1.53 SDSyPAGE buffer and
processed as described above.
Ethidium Bromide (EtBr) Treatment of Lysates. The disruption of
potential contaminating DNA was carried out by treatment with
EtBr (16).
Double-Immunofluorescence and Microscopy. Cos-7 cells were
transfected with a human TdT expression construct (17) by using
Lipofectamine (GIBCOyBRL). After etoposide treatment, cells
were washed with PBS, treated with methanol for 30 min at
220°C, and rinsed briefly with ice-cold acetone as described by
Haaf et al. (18). After three more washes with PBS, the coverslips
were treated with PBS containing 0.2% Triton X-100 for 15 min
at room temperature. The coverslips were washed three times
with PBS, followed by incubation in blocking buffer [PBSy10%
(vol/vol) FCSy3% (wt/vol) BSA] for 1 h at room temperature.
The coverslips were then incubated with blocking solution
containing mouse anti-Ku86 mAbs (1:400 dilution) and rabbit
anti-TdT polyclonal antibodies (1:400 dilution) for 1 h. Cells
were washed three times with PBS, followed by incubation in
FITC-conjugated anti-mouse and rhodamine-conjugated anti-
rabbit secondary antibodies for 1 h at room temperature. Cells
were washed three times with PBS, followed by incubation in
49,6-diamidino-2-phenylindole for 5 min. Coverslips were
washed and mounted on glass slide in Vectashield mounting
medium (Vector Laboratories). For detection of Ku-specific
(FITC) fluorescence, cells were viewed with a filter set having an
excitation filter of 480y20 nm, a dichroic beam splitter of 500 nm,
and an emission filter of 515y30 nm. TdT specific f luorescence
was visualized by using a filter set with an excitation filter of
560y20 nm, a dichroic beam splitter of 570 nm, and an emission
filter of 590 nm (long pass). Fluorescence from 49,6-diamidino-
2-phenylindole in nuclei was viewed with the filter set having an
excitation filter of 390y20 nm, a dichroic beam splitter of 420 nm,
and an emission filter of 450y40 nm. The images were captured
by using a slow-scan cooled charge-coupled device camera
(exposure of 1.3–2 s).
Colocalization. The images from individual nuclei were overlaid
by using a computer algorithm (19). Briefly, a threshold was
selected that obtained the data of interest and converted the
image into a binary image. By using the filter ‘‘IP Boolean AND’’
operation, an image was generated that retained only the data
that were common to both of the input images and thus provided
the extent of colocalization. The filter ‘‘IP Math Subtract’’
function performed on each of the original input images gave the
data that were unique for that particular image.
Results
Interaction of TdT and Ku70y86 Proteins. Genetic and biochemical
data suggest that TdT and Ku may interact physically during
V(D)J recombination in early lymphocyte development (11). To
obtain direct evidence for complex formation, we chose to
overexpress TdT and Ku70y86 and study their interaction (Fig.
1 A and B). Equivalent levels of expression of TdT were observed
after infection with TdT alone or in combination with His-Ku70,
His-Ku86, His-Ku70y86, or ADA (Fig. 1 A, lanes 2–6). Purified
TdT (Fig. 1 A, lane 1) has undergone proteolysis from the 58-kDa
form and migrates as two polypeptides with molecular masses of
55 kDa and 44 kDa, while retaining full catalytic activity.
Infection of Sf9 cells with TdT baculovirus alone or in combi-
nation with ADA resulted in both the 58- and 55-kDa TdT
proteins in cell extracts (Fig. 1 A, lanes 2 and 6). However,
coexpression of TdT either with Ku subunit alone or with both
the subunits together seemed to stabilize TdT in the 58-kDa
form completely (Fig. 1 A, lanes 3–5).
Equal amounts of cell extracts were analyzed for protein–
protein interactions in coimmunoprecipitation experiments with
anti-TdT (133D2; ref. 12) or anti-polyHis mAbs. Immunopre-
cipitation with the anti-polyHis mAb that recognizes the Ku-
His-tagged protein coprecipitated the full-length 58-kDa TdT
Fig. 1. (A) Expression of TdT in Sf9 cells. Sf9 cells were infected with
recombinant baculovirus expressing TdT (lane 2); TdT and His-Ku70 (lane 3);
TdT and His-Ku86 (lane 4); TdT and His-Ku70y86 (lane 5); and TdT and
adenosine deaminase (ADA; lane 6). The baculovirus constructs used for
infections are indicated above the lanes. Lane 1 contains 30 ng of purified TdT.
Extracts were made 72 h after infection, electrophoresed on SDSy10% PAGE,
and transferred to a PVDF membrane. The blot was probed with rabbit
anti-TdT polyclonal antibody at a 1:1,000 dilution and developed by using the
enhanced chemiluminescence method. (B) Coimmunoprecipitation of Ku sub-
units with TdT. Approximately 50 mg of extract obtained from single, double,
or triple coinfections was incubated with the anti-TdT 133D2 (lane 2), anti-
polyHis (lanes 3–5), and anti-ADA N1D1 (lane 6) mouse mAbs. The immuno-
precipitated complexes were resolved by SDSy10% PAGE, transferred to
PVDF, and probed with rabbit anti-TdT polyclonal antibody (1:1,000 dilution).
The blots were developed as described in A.









with each Ku subunit and with the heterodimer in the presence
of 150 mM NaCl (Fig. 1B, lanes 3–5). TdT did not coimmuno-
precipitate with ADA, indicating specificity of the TdT–Ku
interaction (Fig. 1B, lane 6).
The interactions between TdT and Ku subunits were tested
further by using TdT mAb for immunoprecipitation and anti-
polyHis for Western analysis (Fig. 2). Anti-polyHis detected
His-tagged Ku70 (Fig. 2 A, lane 1) and His-tagged Ku86 (Fig. 2 A,
lane 2) but not TdT in cells coinfected with TdT and either of
the Ku subunits alone or in combination (Fig. 2 A, lane 3).
Immunoprecipitation performed with the anti-TdT mAb (Fig.
2B, lanes 4–6) followed by Western analysis with the anti-
polyHis antibody indicated that the Ku70 (Fig. 2B, lane 4), Ku86
(lane 5), or Ku70y86 (lane 6) proteins were present in the
anti-TdT immunoprecipitates after coinfection with either or
both of the Ku proteins, showing further that TdT complexes
with the subunits independently as well as in combination.
TdT–Ku Interaction in Molt-4 Lymphoblasts. Based on the potential
importance of the TdT–Ku interaction during V(D)J recombi-
nation and N region insertion in developing lymphocytes, we
asked whether this interaction could also occur in human
lymphoid cells. Immunoprecipitation of Molt-4 lymphoid cell
extracts by using the anti-TdT mAb followed by Western analysis
revealed a single band of 58 kDa (Fig. 3A Lower, lane 5). The
58-kDa protein was also coimmunoprecipitated with antibodies
to Ku70 (Fig. 3A Lower, lane 2), Ku86 (Fig. 3A Lower, lane 3),
Fig. 2. (A) Expression of Ku subunits in Sf9 cells. Sf9 cells were infected with
recombinant baculovirus expressing TdT and His-Ku70 (lane 1); TdT and
His-Ku86 (lane 2); TdT and His-Ku70y86 (lane 3); and Ku70y86 (lane 4).
Extracts obtained 72 h after infection were electrophoresed on SDSy10%
PAGE and transferred to a PVDF membrane. The blot was probed with
anti-polyHis antibody (1:5,000 dilution) and developed by using the enhanced
chemiluminescence method. (B) Coimmunoprecipitation of TdT with Ku sub-
units. Approximately 50 mg of extract obtained from single, double, or triple
coinfection experiments was incubated with either the anti-polyHis (lanes
1–3) or anti-TdT 133D2 (lanes 4–6) mAbs. The immunoprecipitates were
resolved by SDSy10% PAGE, transferred to PVDF membranes, and probed
with anti-polyHis (1:5,000 dilution) antibody. The blots were developed as
described in Fig. 1. IP, immunoprecipitation.
Fig. 3. (A) TdT–Ku interaction in Molt-4 lymphoblasts. Molt-4 lymphoid cell
extracts (500 mg) were incubated with mAbs specific for Ku 70 (N3H10), Ku86
(111), Ku70y86 (162), or TdT (5100) as indicated above the lanes. Immuno-
precipitated complexes were analyzed as described above. The blot was
serially probed with rabbit anti-TdT (1:500 dilution; Bottom), mouse anti-Ku70
(1:1 dilution; Middle), or mouse anti-Ku86 antibodies (1:4,000 dilution; Top).
The blot had to be exposed for a longer time to obtain a signal corresponding
to Ku86. To prevent overexposure of other lanes, a separate exposure was
obtained and included for lane 5. (B) Effect of EtBr on TdT–Ku interactions.
Protein complexes were immunoprecipitated in the absence (lanes 1–3) or
presence (lanes 4–6) of 100 mgyml EtBr with anti-TdT, anti-Ku70yKu86
heterodimer, and anti-DNA-PKcs mAbs (lanes 1 and 4, 2 and 5, 3 and 6,
respectively) from Molt-4 cell extracts, resolved by SDSyPAGE, and analyzed
by Western blotting by using anti-Ku86 as described in A.
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and the Ku70y86 heterodimer (Fig. 3A Lower, lane 4). The blot
was reprobed with mAbs specific for Ku70 or Ku86. Ku70 and
Ku86 were immunoprecipitated with anti-Ku mAbs (Fig. 3A
Middle and Top, lanes 2–4) as well as the anti-TdT antibody (lane
5). This result suggests that TdT and Ku associate in human
lymphoid cell extracts and that the interaction is not an artifact
of overexpression in Sf9 cells.
TdT and Ku Interaction Is DNA Independent. As TdT and Ku are both
capable of binding DNA, it is important to determine whether
the observed interaction of TdT and Ku could be due to the
presence of contaminating DNA in the cell lysates. Previous
work showed that the Ku and DNA-PKcs interaction is DNA
dependent, whereas heterodimerization between Ku70 and
Ku86 occurs in the absence of DNA (3, 13). To test for
DNA-dependent interactions, immunoprecipitations were per-
formed by using Molt-4 cell extracts treated with 100 mgyml
EtBr (16). TdT, Ku70yKu86, and DNA-PKcs immunoprecipi-
tates were tested for the presence of Ku86 by Western analysis
(Fig. 3B). In the absence of EtBr, Ku86 was found to be
coimmunoprecipitated with TdT, Ku70, and DNA-PKcs (Fig.
3B, lanes 1–3). However, in the presence of EtBr, the Ku and
DNA-PKcs interaction was specifically disrupted, whereas the
TdT–Ku86 and Ku86–Ku70 interactions remained intact (Fig.
3B, lanes 4–6).
Additional evidence for DNA-independent interactions be-
tween Ku and TdT is the association between TdT and each Ku
subunit. The Ku86 subunit alone does not bind DNA, and the
Ku70–DNA interaction is weak in the absence of Ku86 (20).
Further, it has been shown that at 500 mM NaCl, DNA disso-
ciates from Ku (21), whereas the TdT–Ku86 complex is stable at
this salt concentration.
The N-Terminal 131 Amino Acids of TdT Are Essential for the TdT–Ku
Interaction. To identify the domains in TdT that interact with Ku,
we constructed a 44-kDa truncated form of TdT in which 131
amino acids at the N terminus containing the BRCT domain
were deleted. This form of TdT, which is also generated by
proteolysis of full-length TdT in cell extracts, retains the DNA
and nucleotide binding domains and is fully active. Sf9 insect
cells were infected with 44-kDa TdT, in conjunction with His-
tagged Ku70, Ku86, or both Ku70 and Ku86. The expression of
each protein was monitored by Western analysis (Fig. 4A).
Coimmunoprecipitation with the anti-polyHis mAb followed by
Western blotting for TdT revealed that 44-kDa TdT strongly and
specifically interacted with the Ku86 subunit (Fig. 4B, lane 7),
whereas a weaker or no interaction was observed in cells
expressing the Ku heterodimer (Fig. 4B, lanes 8 and 9). The
interaction with the 70-kDa subunit was lost (Fig. 4B, lane 6),
suggesting that the BRCT domain is necessary for TdT–Ku70
and TdT–Ku heterodimer interaction.
Colocalization of TdT and Ku After DNA Damage. The interaction of
TdT with Ku was also examined in intact cells by using a
double-immunofluorescence technique (22). To overcome the
limitation of the small size of Molt-4 nuclei and low level of TdT
expression, we performed the experiments in Cos-7 cells con-
taining endogenous Ku that were transiently transfected with a
human TdT expression construct (17). Expression of both Ku
and TdT in vivo was confirmed by staining cells with anti-Ku and
anti-TdT primary antibodies, followed by incubation with sheep
FITC-conjugated anti-mouse (anti-Ku, green fluorescence) and
goat-rhodamine conjugated anti-rabbit (anti-TdT, red fluores-
cence) IgG secondary antibodies. Under normal growth condi-
tions, both proteins were uniformly distributed in the nucleus
(Fig. 5 A and B). To test whether the induction of DSBs, similar
to those that occur during V(D)J recombination (1), would alter
the distribution of the TdT and Ku proteins, Cos-7 cells trans-
fected with TdT were treated with etoposide, a topoisomerase II
inhibitor. Untreated cells did not have clear foci or colocalization
of Ku and TdT (Table 1). After 3 h of treatment with 2 mM
etoposide, numerous distinct bright spots or foci of TdT and Ku
immunofluorescence were observed; they were consistently vis-
ible in three independent experiments (Fig. 5 C and D). Quan-
titative analysis revealed that, after 3 h, '10% of the cells were
positive for Ku foci and '14% were positive for TdT foci when
examined individually for each of the proteins. At 5 h, there was
an increase in the number of nuclei showing foci (Table 1).
Greater than 80% of TdT foci-positive nuclei were also positive
for Ku foci at both 3 and 5 h after etoposide treatment. TdT and
Ku foci were not detectable in the nucleolus, where TdT staining
has also been found to be weak (23).
The possibility that TdT and Ku were interacting after the
induction of DSBs was tested by measurement of colocalization
Fig. 4. (A) Expression of 44-kDa N-terminal truncation of TdT. Extracts from
uninfected (lane 2) or baculovirus-infected Sf9 cells expressing 44-kDa TdT
(lane 3), 44-kDa TdT with Ku70 (lane 4), 44-kDa TdT with Ku86 (lane 5), 44-kDa
TdT with Ku70y86 heterodimer (lane 6), or 44-kDa TdT with ADA (lane 7) were
analyzed by Western blotting by using rabbit polyclonal anti-TdT. (B) Coim-
munoprecipitation of 44-kDa TdT with Ku86. Extracts from uninfected Sf9 cells
(lane 1) or cells infected with baculovirus expressing 44-kDa TdT (lanes 2–5),
44-kDa TdT with Ku70 (lane 6), 44-kDa TdT with Ku86 (lane 7), 44-kDa TdT with
Ku70y86 (lanes 8 and 9), or 44-kDa TdT with ADA (lane 10) were immuno-
precipitated with anti-TdT (lane 2), anti-ADA (lanes 3 and 10), anti-Ku het-
erodimer (anti-162; lanes 4 and 9), or anti-His (anti-Ku; lanes 5–8) and ana-
lyzed as described for A.









of foci. Images of the nuclei were acquired first with FITC
(green) filters (Ku localization) and subsequently with rhoda-
mine (red) filters (TdT localization). Images obtained from the
same nucleus that had been stained with both antibodies were
analyzed by using a computer program designed to measure the
extent of colocalization (19). Results of analyses from five nuclei
showed that colocalized TdT and Ku foci were scattered at many
locations in the nucleus. A representative nucleus is shown in
Fig. 6. The Ku and TdT foci that are not colocalized (Fig. 6 A
and B) in comparison with clearly colocalized regions (Fig. 6C)
are shown. Quantitative analysis of individual nuclei based on
the number of overlapping pixels revealed that 10–25% of TdT
foci were colocalized with Ku in response to etoposide treat-
ment. Importantly, as the program performs pixel by pixel
analysis, only those pixels that are coincident in both images are
used to obtain the colocalization image, avoiding any possibility
of fortuitous colocalization. A similar extent of TdT–Ku colo-
calization was observed in all nuclei that contained TdT or Ku
DSB-induced foci.
Discussion
We have shown that full-length TdT interacts directly with the
Ku70y86 heterodimeric protein, as well as with each subunit
independently, and that this interaction stabilizes TdT against
proteolysis. In contrast to the Ku–DNA-PKcs interaction, the
interaction of TdT with the Ku subunits and with the het-
erodimeric protein is DNA independent. Of particular interest
is the observation that the N-terminal 131 amino acids of TdT
that encompass a BRCT domain were required for the interac-
tion of TdT with Ku70 but not with the Ku86 subunit or with the
heterodimeric protein. The BRCT motif is found in a number of
DNA repair proteins and seems to mediate protein–protein
interactions, such as those found in XRCC1 and DNA ligase III,
where it exists as an independent folding region (8, 9). It seems
likely that this evolutionarily conserved motif may play an
important role in recruiting TdT to the ends of DNA DSBs.
Our data on TdT–Ku interactions have significant implica-
tions for V(D)J recombination. Ku protein binds at the sites of
DNA DSBs and is required for the resolution of signal and
coding junction intermediates generated during the recombina-
tion process (10). We and others have shown that TdT mediates
N region insertions at both signal and coding junctions (17, 24).
Our results indicate that TdT may be recruited to the recombi-
nation sites by direct contacts with Ku. This interaction may
modulate TdT activity at the recombination intermediates.
Support for this hypothesis comes from the recent direct dem-
onstration that Ku862y2 mice lack N region insertions at coding
joints (11).
Recent experiments have identified regions of the Ku70 and
86 subunits that are required for heterodimerization. The C-
terminal half of Ku86 (amino acids 334–732) containing a
proline-rich domain is essential for its dimerization to Ku70 and
subsequent DNA binding activity (25). Truncation of the C-
terminal portion of Ku86 in an HL-60 cell line resulted in
diminished DNA binding and heterodimerization abilities as
well as in defective interactions with DNA-PKcs (26). The
C-terminal portion of the p70 subunit directly binds double-
stranded DNA in the absence of heterodimerization with p86,
and two distinct dimerization domains at the N terminus and at
amino acids 430–482 have been identified (20). Functional roles
for leucine zipper motifs found in both p70 and p86 have not
been identified (15, 25). Although direct experimental data are
lacking and TdT does not have a canonical leucine zipper region,
it is conceivable that the Ku leucine zippers could play a role in
DNA-PKcs interactions or in TdT–Ku interactions.
Further evidence for a model in which TdT and Ku interact at
sites of DSBs is the formation of colocalized nuclear foci of TdT
and Ku proteins in cells induced to undergo DSBs. These results
Fig. 5. Double-immunoflourescence analysis of Cos-7 cells transfected with
human TdT: effect of etoposide treatment. Cos-7 cells transfected with the
human TdT expression construct were treated with 2 mM of etoposide in
DMSO (C and D) or DMSO alone (A and B) for 3–5 h and fixed. Cells were
stained with FITC-aKu (green) or rhodamine-aTdT (red). Both proteins are
present only in the nucleus.
Fig. 6. Colocalization of TdT and Ku after etoposide treatment. Images
obtained from the same treated nucleus stained for FITC-aKu (green; A) and
rhodamine-aTdT (red; B) were digitized. By using the image processing tool kit
(20) in ADOBE PHOTOSHOP 4.01, the foci that were not colocalized for both Ku or
TdT were subtracted (A and B), and only Ku and TdT foci that were truly
colocalized remained (yellow; C). (D) DNA counterstained with 49,6-
diamidino-2-phenylindole (blue).


















No treatment 216 0 107 0
3 258 10 209 14
5 383 14 229 21
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provide in vivo evidence for the formation of TdT and Ku
complexes in cells treated with DSB-inducing agents. A study by
Maser et al. (22) shows that two of the DSB repair proteins,
human Mre11 and human Rad50, colocalize in discrete nuclear
foci after treatment with agents that induce DSBs, whereas Haaf
and coworkers (18, 27) show that another DNA repair and
recombination protein, human Rad51, localizes in nuclear foci
after exposure to g-irradiation or etoposide treatment. Foci of
Ku and TdT colocalized in greater than 80% of the cells, and the
extent of colocalization was 10–25%. Recent data show that
human Rad51 and RPA (Replication Protein A) foci were
colocalized and that .10% of human Rad51 foci were localized
at sites of DNA damage (28). We postulate that the TdT–Ku
interaction may exist in a dynamic equilibrium, possibly relating
to the extent of TdT proteolysis. The in vivo interaction of TdT
with Ku suggests that polymerization by TdT occurs at exog-
enously induced DSBs. Whether this interaction occurs before
the recruitment of a preformed complex of TdT–Ku to DNA
break sites or by interaction after independent protein localiza-
tion at DNA ends is currently unclear. It is also unknown
whether the localization of TdT at DSB sites could further
sensitize TdT-expressing pre-B or pre-T cells to DSB-inducing
agents, such as ionizing radiation by catalyzing nucleotide ad-
ditions at these sites (29).
Recent reports suggest that the Saccharomyces cerevisiae
complex of ScRAD50, ScMre11, and ScXRS2 participate in
Ku-dependent DNA DSB repair. One function of this trimeric
complex could be to serve as a bridge between Ku and other
members of the nonhomologous end-joining pathway (30). It will
be important to determine whether human TdT and Ku are
shared components in a DSB repair pathway of developing
lymphocytes that may also include the human homologs of
Mre11, p95, and Rad50. Furthermore, it will be of interest to
pursue the potential for detrimental effects of TdT activity at
sites of DSBs not involved in V(D)J recombination in TdT-
positive cell lines.
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